title: Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy.
authors.affiliation: Deloitte, Diegem, Belgium.
authors.forename: H
authors.initials: H
authors.lastname: Akpo
authors.affiliation: Janssen Pharmaceutica NV, Beerse, Belgium.
authors.forename: K
authors.initials: K
authors.lastname: Cerri
authors.affiliation: Janssen Global Services, Beerse, Belgium.
authors.forename: U
authors.initials: U
authors.lastname: Sbarigia
authors.affiliation: London School of Economics and Political Science, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Kleintjens